Holen Sie sich die Stockscreener-App
323.25
1.92%
6.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MDGL?
Forum
Prognose
Aktiensplit
Finanzdaten der Madrigal Pharmaceuticals Inc-Aktie (MDGL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
29.75%
152.04
|
117.18 | 98.53 | 86.45 | 78.34 |
| Interest Income/Expense |
3.35%
3.838
|
3.971 | 3.504 | 2.901 | 2.336 |
| Operating Income/Loss |
29.75%
-152.04
|
-117.18 | -98.53 | -86.45 | -78.34 |
| Income/Loss From Continuing Operations Before Tax |
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
| Income/Loss From Continuing Operations After Tax |
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
|
Net Income/Loss
|
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.22%
20.00
|
19.76 | 18.48 | 18.31 | 18.19 |
| Diluted Average Shares |
1.22%
20.00
|
19.76 | 18.48 | 18.31 | 18.19 |
| Basic Earnings Per Share |
29.93%
-7.38
|
-5.68 | -5.34 | -4.69 | -4.23 |
| Diluted Earnings Per Share |
29.93%
-7.38
|
-5.68 | -5.34 | -4.69 | -4.23 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):